DENVER, Colo. (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ:NTHI) is stepping into the national spotlight as its brain cancer research advances alongside a growing international presence. The clinical-stage biotech is scheduled to be featured on Health Uncensored with Dr. Drew on Fox Business Network this Sunday, October 25, at 5:30 p.m. ET. The appearance comes on the heels of significant developments in the company’s investigational brain tumor programs and its proposed research collaboration with Abu Dhabi’s Department of Health, bringing fresh attention to NeOnc’s pursuit of new approaches to treating aggressive central nervous system cancers.
CEO Amir F. Heshmatpour and founder and Chief Scientific Officer Thomas Chen, MD, PhD, will discuss NeOnc’s approach to a persistent challenge in oncology: delivering potential treatments to tumors inside the brain while navigating the protective blood-brain barrier. The company’s intranasal candidate, NEO100, is designed to provide a non-invasive route for delivering therapy to the brain without relying on surgery or systemic chemotherapy as the delivery method.
The television appearance comes just days after NeOnc announced a memorandum of understanding with Abu Dhabi’s Department of Health to explore collaboration in CNS cancer research, clinical development expertise, specialist training and real-world evidence. The framework also contemplates evaluating future clinical studies and the possibility of a regional presence.
The company has also reported early clinical observations involving a critically ill three-year-old boy receiving investigational NEO100 through its Compassionate Care program in Abu Dhabi. His treating physicians reported that he was breathing independently without ventilator support and beginning to move his legs after treatment began.
Together, the developments provide a compelling narrative: a biotech seeking to advance a different approach to brain tumor treatment, build international research relationships and bring its work to a wider audience. Heshmatpour summarized the ambition in the company’s recent announcement: “We believe that we will make a significant impact in the standard of care for adults and kids suffering with brain cancer.”
NeOnc’s Fox Business appearance arrives as its scientific mission gains visibility and its Abu Dhabi activities expand.
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247mnn.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.
Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.
CONTACT:
24/7 Market News
Editor@247mnn.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.